These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 28792144)

  • 1. Comparison of Multiparametric and Biparametric MRI in First Round Cognitive Targeted Prostate Biopsy in Patients with PSA Levels under 10 ng/mL.
    Lee DH; Nam JK; Lee SS; Han JY; Lee JW; Chung MK; Park SW
    Yonsei Med J; 2017 Sep; 58(5):994-999. PubMed ID: 28792144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the Diagnostic Accuracy of Biparametric Magnetic Resonance Imaging for Prostate Cancer in Biopsy-Naive Men: The Biparametric MRI for Detection of Prostate Cancer (BIDOC) Study.
    Boesen L; Nørgaard N; Løgager V; Balslev I; Bisbjerg R; Thestrup KC; Winther MD; Jakobsen H; Thomsen HS
    JAMA Netw Open; 2018 Jun; 1(2):e180219. PubMed ID: 30646066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abbreviated Biparametric Prostate MR Imaging in Men with Elevated Prostate-specific Antigen.
    Kuhl CK; Bruhn R; Krämer N; Nebelung S; Heidenreich A; Schrading S
    Radiology; 2017 Nov; 285(2):493-505. PubMed ID: 28727544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiparametric MRI in detection and staging of prostate cancer.
    Boesen L
    Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative prostate biopsy and multiparametric magnetic resonance imaging: reliability in detecting prostate cancer.
    Porpiglia F; Russo F; Manfredi M; Mele F; Fiori C; Regge D
    Int Braz J Urol; 2015; 41(1):124-33. PubMed ID: 25928518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An initial negative round of targeted biopsies in men with highly suspicious multiparametric magnetic resonance findings does not exclude clinically significant prostate cancer-Preliminary experience.
    Costa DN; Kay FU; Pedrosa I; Kolski L; Lotan Y; Roehrborn CG; Hornberger B; Xi Y; Francis F; Rofsky NM
    Urol Oncol; 2017 Apr; 35(4):149.e15-149.e21. PubMed ID: 27939349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visually Estimated MRI Targeted Prostate Biopsy Could Improve the Detection of Significant Prostate Cancer in Patients with a PSA Level <10 ng/mL.
    Lee DH; Nam JK; Park SW; Lee SS; Han JY; Lee SD; Lee JW; Chung MK
    Yonsei Med J; 2016 May; 57(3):565-71. PubMed ID: 26996553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiparametric MRI of the prostate with three functional techniques in patients with PSA elevation before initial TRUS-guided biopsy.
    Hauth E; Hohmuth H; Cozub-Poetica C; Bernand S; Beer M; Jaeger H
    Br J Radiol; 2015 Oct; 88(1054):20150422. PubMed ID: 26268144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of biparametric magnetic resonance imaging (MRI) as an adjunct to prostate-specific antigen (PSA)-based detection of prostate cancer in men without prior biopsies.
    Rais-Bahrami S; Siddiqui MM; Vourganti S; Turkbey B; Rastinehad AR; Stamatakis L; Truong H; Walton-Diaz A; Hoang AN; Nix JW; Merino MJ; Wood BJ; Simon RM; Choyke PL; Pinto PA
    BJU Int; 2015 Mar; 115(3):381-8. PubMed ID: 24447678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer.
    Kuru TH; Roethke MC; Seidenader J; Simpfendörfer T; Boxler S; Alammar K; Rieker P; Popeneciu VI; Roth W; Pahernik S; Schlemmer HP; Hohenfellner M; Hadaschik BA
    J Urol; 2013 Oct; 190(4):1380-6. PubMed ID: 23608676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biparametric 3T Magnetic Resonance Imaging for prostatic cancer detection in a biopsy-naïve patient population: a further improvement of PI-RADS v2?
    Stanzione A; Imbriaco M; Cocozza S; Fusco F; Rusconi G; Nappi C; Mirone V; Mangiapia F; Brunetti A; Ragozzino A; Longo N
    Eur J Radiol; 2016 Dec; 85(12):2269-2274. PubMed ID: 27842676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The feasibility of multiparametric magnetic resonance imaging for targeted biopsy using novel navigation systems to detect early stage prostate cancer: the preliminary experience.
    Mouraviev V; Verma S; Kalyanaraman B; Zhai QJ; Gaitonde K; Pugnale M; Donovan JF
    J Endourol; 2013 Jul; 27(7):820-5. PubMed ID: 22966987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic accuracy of biparametric vs multiparametric MRI in clinically significant prostate cancer: Comparison between readers with different experience.
    Di Campli E; Delli Pizzi A; Seccia B; Cianci R; d'Annibale M; Colasante A; Cinalli S; Castellan P; Navarra R; Iantorno R; Gabrielli D; Buffone A; Caulo M; Basilico R
    Eur J Radiol; 2018 Apr; 101():17-23. PubMed ID: 29571792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved detection of anterior fibromuscular stroma and transition zone prostate cancer using biparametric and multiparametric MRI with MRI-targeted biopsy and MRI-US fusion guidance.
    Radtke JP; Boxler S; Kuru TH; Wolf MB; Alt CD; Popeneciu IV; Steinemann S; Huettenbrink C; Bergstraesser-Gasch C; Klein T; Kesch C; Roethke M; Becker N; Roth W; Schlemmer HP; Hohenfellner M; Hadaschik BA
    Prostate Cancer Prostatic Dis; 2015 Sep; 18(3):288-96. PubMed ID: 26078202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiparametric magnetic resonance imaging outperforms the Prostate Cancer Prevention Trial risk calculator in predicting clinically significant prostate cancer.
    Salami SS; Vira MA; Turkbey B; Fakhoury M; Yaskiv O; Villani R; Ben-Levi E; Rastinehad AR
    Cancer; 2014 Sep; 120(18):2876-82. PubMed ID: 24917122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of Biparametric Magnetic Resonance Imaging Combined With Prostate Specific Antigen Density in Pre-biopsy Detection of Clinically Insignificant Prostate Cancer.
    Sekito S; Terabe T; Shibahara T; Onishi T
    Anticancer Res; 2021 Apr; 41(4):2183-2186. PubMed ID: 33813431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel biparametric MRI and targeted biopsy improves risk stratification in men with a clinical suspicion of prostate cancer (IMPROD Trial).
    Jambor I; Boström PJ; Taimen P; Syvänen K; Kähkönen E; Kallajoki M; Perez IM; Kauko T; Matomäki J; Ettala O; Merisaari H; Kiviniemi A; Dean PB; Aronen HJ
    J Magn Reson Imaging; 2017 Oct; 46(4):1089-1095. PubMed ID: 28165653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MRI-directed cognitive fusion-guided biopsy of the anterior prostate tumors.
    Murphy IG; NiMhurchu E; Gibney RG; McMahon CJ
    Diagn Interv Radiol; 2017; 23(2):87-93. PubMed ID: 28074780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate cancer detection using multiparametric 3 - tesla MRI and fusion biopsy: preliminary results.
    Mussi TC; Garcia RG; Queiroz MR; Lemos GC; Baroni RH
    Int Braz J Urol; 2016; 42(5):897-905. PubMed ID: 27532112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toward an MRI-based nomogram for the prediction of transperineal prostate biopsy outcome: A physician and patient decision tool.
    Lee SM; Liyanage SH; Wulaningsih W; Wolfe K; Carr T; Younis C; Van Hemelrijck M; Popert R; Acher P
    Urol Oncol; 2017 Nov; 35(11):664.e11-664.e18. PubMed ID: 28801025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.